By hgreaney@athen…, 16 September, 2021 Individualize decision to withhold continue increase immunosuppression in IBD pts per AGA 4 though ACG recommends against holding immunosuppressants 2 may be reasonable to start steroids or uarr immunosuppression after a few days of abx if no improvement2
By hgreaney@athen…, 16 September, 2021 Avoid antimotility agents in untreated CDI but they can be used safely on an as needed basis after anti CDI tx initiated2
By hgreaney@athen…, 16 September, 2021 Consider adding bezlotoxumab to SOC abx in adults 65 yo or immunocompromised 6 per ACG reserve for pts who are both age 65 yo immunocompromised7
By hgreaney@athen…, 16 September, 2021 In children metronidazole recommended as initial agent by AAP 3 but vancomycin also 1st line per IDSA5
By hgreaney@athen…, 16 September, 2021 In IBD vancomycin preferred AGA 10 days ACG 14 days 2 4 though AGA suggests fidaxomicin as option
By hgreaney@athen…, 16 September, 2021 Use fidaxomicin over vancomycin in adults per IDSA 1 both are options per ACG but not in pregnancy breastfeeding 2 or children3
By hgreaney@athen…, 16 September, 2021 D c precipitating antibiotic fidaxomicin now preferred in adults by IDSA but vancomycin remains an option additional tx may be considered
